经皮外周神经刺激治疗术后疼痛:随机假对照预试验
该多中心随机假对照预试验评估经皮外周神经刺激对门诊骨科手术术后疼痛的疗效。术前经皮植入电极靶向坐骨神经、股神经或臂丛,并注射长效局麻药;术后随机接受14天电刺激(n=32)或假刺激(n=34)。术后7天内,电刺激组阿片消耗量中位数5 mg(0-30)显著低于假刺激组48 mg(25-90),平均疼痛评分1.1±1.1显著低于3.1±1.7。
要点
- 经皮外周神经刺激可减少术后7天阿片类药物消耗和疼痛评分
- 效应量:阿片消耗几何均值比0.20(97.5%CI 0.07-0.57),疼痛评分差-1.8(97.5%CI -2.6至-0.9)
- 该技术为门诊骨科手术术后镇痛提供无全身副作用的辅助手段
核心结论
- 经皮外周神经刺激在门诊骨科手术术后至少第一周内减轻疼痛评分并减少阿片需求,且无全身副作用。
研究设计与样本
- 多中心随机假对照预试验,术前经皮植入电极靶向坐骨神经、股神经或臂丛,并注射长效局麻药;术后双盲随机接受14天电刺激(n=32)或假刺激(n=34)。
主要发现
- 术后7天内,电刺激组阿片消耗中位数5 mg(IQR 0-30),假刺激组48 mg(IQR 25-90),几何均值比0.20(97.5%CI 0.07-0.57),P<0.001。
- 术后7天内,电刺激组平均疼痛评分1.1±1.1,假刺激组3.1±1.7,差值-1.8(97.5%CI -2.6至-0.9),P<0.001。
临床怎么用
- 对于门诊骨科手术(如拇外翻矫正、前交叉韧带重建、肩袖修复),可考虑术前经皮植入外周神经刺激电极作为术后镇痛辅助,以减少阿片消耗和疼痛评分。
局限性
- 本研究为预试验,样本量较小(电刺激组32例,假刺激组34例),主要目的是评估可行性和优化方案,疗效需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Percutaneous peripheral nerve stimulation is an analgesic technique involving the percutaneous implantation of a lead followed by the delivery of electric current using an external pulse generator. Percutaneous peripheral nerve stimulation has been used extensively for chronic pain, but only uncontrolled series have been published for acute postoperative pain. The current multicenter study was undertaken to (1) determine the feasibility and optimize the protocol for a subsequent clinical trial and (2) estimate the treatment effect of percutaneous peripheral nerve stimulation on postoperative pain and opioid consumption. METHODS: Preoperatively, an electrical lead was percutaneously implanted to target the sciatic nerve for major foot/ankle surgery (e.g., hallux valgus correction), the femoral nerve for anterior cruciate ligament reconstruction, or the brachial plexus for rotator cuff repair, followed by a single injection of long-acting local anesthetic along the same nerve/plexus. Postoperatively, participants were randomized to 14 days of either electrical stimulation (n = 32) or sham stimulation (n = 34) using an external pulse generator in a double-masked fashion. The dual primary treatment effect outcome measures were (1) cumulative opioid consumption (in oral morphine equivalents) and (2) mean values of the "average" daily pain scores measured on the 0 to 10 Numeric Rating Scale within the first 7 postoperative days. RESULTS: During the first 7 postoperative days, opioid consumption in participants given active stimulation was a median (interquartile range) of 5 mg (0 to 30) versus 48 mg (25 to 90) in patients given sham treatment (ratio of geometric means, 0.20 [97.5% CI, 0.07 to 0.57]; P < 0.001). During this same period, the average pain intensity in patients given active stimulation was a mean ± SD of 1.1 ± 1.1 versus 3.1 ± 1.7 in those given sham (difference, -1.8 [97.5% CI, -2.6 to -0.9]; P < 0.001). CONCLUSIONS: Percutaneous peripheral nerve stimulation reduced pain scores and opioid requirements free of systemic side effects during at least the initial week after ambulatory orthopedic surgery.
引用
- Ilfeld BM, Plunkett A, Vijjeswarapu AM, et al. Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Pain: A Randomized, Sham-controlled Pilot Study. Anesthesiology. 2021. PMID: 33856424. doi:10.1097/ALN.0000000000003776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。